Clinical Trial Update: Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating encorafenib and binimetinib before local treatment in patients with BRAF-mutant melanoma that has spread to the brain; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Drugs mentioned

• Binimetinib (binimetinib)
• Encorafenib (encorafenib)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Metastatic Melanoma, Brain Metastases | Phase 2 | Status: COMPLETED | Results posted: 2025-05-13